Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease
- 28 July 2006
- journal article
- research article
- Published by Elsevier in Neuropsychologia
- Vol. 45 (2) , 357-367
- https://doi.org/10.1016/j.neuropsychologia.2006.06.014
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2005
- A componential analysis of task‐switching deficits associated with lesions of left and right frontal cortexBrain, 2004
- Defining the Neural Mechanisms of Probabilistic Reversal Learning Using Event-Related Functional Magnetic Resonance ImagingJournal of Neuroscience, 2002
- Mechanisms of cognitive set flexibility in Parkinson's diseaseBrain, 2001
- Enhanced or Impaired Cognitive Function in Parkinson's Disease as a Function of Dopaminergic Medication and Task DemandsCerebral Cortex, 2001
- The effect of dopamine depletion from the caudate nucleus of the common marmoset (Callithrix jacchus) on tests of prefrontal cognitive function.Behavioral Neuroscience, 2000
- COGNITIVE IMPAIRMENT IN EARLY, UNTREATED PARKINSON'S DISEASE AND ITS RELATIONSHIP TO MOTOR DISABILITYBrain, 1991
- Neuropsychological functioning in hemiparkinsonismBrain and Cognition, 1989
- INTERNAL VERSUS EXTERNAL CUES AND THE CONTROL OF ATTENTION IN PARKINSON'S DISEASEBrain, 1988
- Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and CortexAnnual Review of Neuroscience, 1986